PNU-248686A | m-entrepreneurship.com

Product Name :
PNU-248686A

Search keywords :
PNU-248686A

drugId :
null

Target Vo:
Matrix metalloproteinase 13

Target Vo Short Name :
MMP13

Moa_Name:
Matrix metalloproteinase-2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PI3 Kinase p110 gamma (Y10P59) Mouse mAb Epigenetics
MEK1/2 Rabbit mAb Technical Information
c-Myc Tag Antibody(HRP) (YA866): c-Myc Tag Antibody(HRP) (YA866) is a c-Myc tag-conjugated, mouse-derived monoclonal antibody. c-Myc Tag Antibody(HRP) (YA866) can be used for: WB, ELISA, IHC-P, IP expriments in species-independent background.

Author: Betaine hydrochloride

Related Posts